Skip to Main Content

Paper Details

Genomic Aberrations in Circulating Tumor DNAs from Palbociclib-Treated Metastatic Breast Cancer Patients Reveal a Novel Resistance Mechanism.
Cancers (Basel)
1
2022
91 genes, Circulating Tumor DNAs, Circulating cell-free DNAs, ER, IBC, MBC, Metastatic Breast Cancer, Palbociclib, Patients, blood, cfDNA, cfDNA samples, cfDNAs, circulating, circulating tumor DNA, cyclin-dependent kinase 4/6, estrogen, estrogen receptor, inflammatory breast cancer, metastatic breast cancer, non, non-, non-IBC, palbociclib, patients

Datasets

Release 1.2